Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Not yet recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 27Neoplasms 25Lung Neoplasms 12Uterine Cervical Neoplasms 11Colorectal Neoplasms 10Colonic Neoplasms 8Motor Activity 7Urinary Bladder Neoplasms 6Rectal Neoplasms 6Vulvar Neoplasms 5Obesity 5Endometrial Neoplasms 5Carcinoma, Non-Small-Cell Lung 5Melanoma 4Head and Neck Neoplasms 4Anxiety Disorders 4Stomach Neoplasms 3Sarcoma 3Prostatic Neoplasms 3Papillomavirus Infections 3Lymphoma 3Hematopoietic and Lymphoid System Neoplasm 3Hematologic Neoplasms 3Depression 3Carcinoma, Ovarian Epithelial 3Breast Carcinoma In Situ 3Vaginal Neoplasms 2Testicular Neoplasms 2Smoking Cessation 2Skin Neoplasms 2

Interventions

Dexamethasone 5Magnetic Resonance Spectroscopy 4Cyclophosphamide 4Blood Specimen Collection 4Surveys and Questionnaires 3Prednisone 3Melphalan 3Lenalidomide 3Biopsy, Fine-Needle 3fluciclovine F-18 2carfilzomib 2Positron-Emission Tomography 2Mammography 2Injections 2Immunohistochemistry 2Gemcitabine 2Cytarabine 22-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 2weifuchun 1vistusertib 1venetoclax 1technetium 99m 1-(1-(2-(bis(carboxymethyl)amino)-2-oxoethyl)-1H-imidazol-2-yl)-2-((1-(2-(bis(carboxymethyl)amino)-2-oxoethyl)-1H-imidazol-2-yl)methyl)-9,14-dioxo-2,8,13,15-tetraazaoctadecane-7,12,16,18-tetracarboxylic acid) 1ricolinostat 1pomalidomide 1phosphoribosylformylglycinamidine synthetase 1pembrolizumab 1ofatumumab 1obinutuzumab 1lortalamine 1irinotecan sucrosofate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Disease × Methods × Clear all
NCT02308384 2017-04-27

A Trial of the Implementation of iFOBT in General Practice

University of Aarhus

Phase NA Completed
825 enrolled
Gastrointestinal

Disease, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡